We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DEY FILES AMENDEMENT OVER EON PATENT CHALLENGE
DEY FILES AMENDEMENT OVER EON PATENT CHALLENGE
October 5, 2004
Responding to a patent challenge from generic firm Eon Labs, drugmaker Dey has filed an amendment to an earlier citizen petition which entitles Dey—not Ivax, as originally identified—to a 30-month stay on its inhalation lung disease treatment, DuoNeb.